ORI
Oak Ridge Investments Portfolio holdings
AUM
$1.39B
1-Year Return
33.33%
This Quarter Return
+11.86%
1 Year Return
+33.33%
3 Year Return
+165.84%
5 Year Return
+254.68%
10 Year Return
+830.04%
AUM
$1.28B
AUM Growth
+$93.1M
(+7.8%)
Cap. Flow
-$44.9M
Cap. Flow
% of AUM
-3.5%
Top 10 Holdings %
Top 10 Hldgs %
30.96%
Holding
191
New
18
Increased
41
Reduced
115
Closed
13
Top Buys
| 1 |
Microsoft
MSFT
|
$11.6M |
| 2 |
Amazon
AMZN
|
$10.2M |
| 3 |
Netflix
NFLX
|
$9.72M |
| 4 |
Meta Platforms (Facebook)
META
|
$9.12M |
| 5 |
Roper Technologies
ROP
|
$6.09M |
Top Sells
| 1 |
LVGO
Livongo Health, Inc. Common Stock
LVGO
|
$22.9M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$15.5M |
| 3 |
Waste Connections
WCN
|
$14M |
| 4 |
Ametek
AME
|
$10.4M |
| 5 |
Coca-Cola
KO
|
$10.1M |
Sector Composition
| 1 | Technology | 33.07% |
| 2 | Healthcare | 18.43% |
| 3 | Consumer Discretionary | 10.4% |
| 4 | Industrials | 8.6% |
| 5 | Communication Services | 8.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Charter Communications
CHTR
$35.4B
| $5.73M | 0.45% |
9,182
+395
| +4% | +$247K |
|
77
Fortinet
FTNT
$58.6B
| $5.72M | 0.45% |
242,710
-2,870
| -1% | -$67.6K |
|
78
Vertex Pharmaceuticals
VRTX
$102B
| $5.71M | 0.44% |
20,995
-300
| -1% | -$81.6K |
|
79
Frontdoor
FTDR
$4.61B
| $5.66M | 0.44% |
145,517
-18,941
| -12% | -$737K |
|
80
Palomar
PLMR
$3.38B
| $5.63M | 0.44% |
54,034
-3,428
| -6% | -$357K |
|
81
KLA
KLAC
$115B
| $5.55M | 0.43% |
28,618
-233
| -0.8% | -$45.1K |
|
82
Repay Holdings
RPAY
$490M
| $5.53M | 0.43% |
235,271
-31,772
| -12% | -$747K |
|
83
Five Below
FIVE
$8.43B
| $5.43M | 0.42% |
42,728
-2,716
| -6% | -$345K |
|
84
Pinterest
PINS
$25.2B
| $5.32M | 0.41% |
+128,187
| New | +$5.32M |
|
85
argenx
ARGX
$44.9B
| $5.13M | 0.4% |
19,542
-1,342
| -6% | -$352K |
|
86
Kinsale Capital Group
KNSL
$10.7B
| $5.07M | 0.39% |
26,639
-1,814
| -6% | -$345K |
|
87
Enovis
ENOV
$1.8B
| $5.05M | 0.39% |
93,524
-16,113
| -15% | -$870K |
|
88
RBC Bearings
RBC
$12.3B
| $5.01M | 0.39% |
41,336
-6,372
| -13% | -$772K |
|
89
Veracyte
VCYT
$2.48B
| $4.99M | 0.39% |
+153,464
| New | +$4.99M |
|
90
Heron Therapeutics
HRTX
$202M
| $4.94M | 0.38% |
333,501
-27,640
| -8% | -$410K |
|
|
XLRN
91
DELISTED
Acceleron Pharma Inc.
XLRN
| $4.87M | 0.38% |
43,257
-3,016
| -7% | -$339K |
|
|
ALXN
92
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $4.78M | 0.37% |
41,759
-552
| -1% | -$63.2K |
|
93
Arrowhead Research
ARWR
$3.87B
| $4.74M | 0.37% |
110,101
-7,851
| -7% | -$338K |
|
94
Schrodinger
SDGR
$1.4B
| $4.72M | 0.37% |
+99,294
| New | +$4.72M |
|
95
Zynex
ZYXI
$45.1M
| $4.65M | 0.36% |
+293,277
| New | +$4.65M |
|
96
Mesa Laboratories
MLAB
$354M
| $4.45M | 0.35% |
17,452
-1,301
| -7% | -$331K |
|
97
Marsh & McLennan
MMC
$101B
| $4.31M | 0.34% |
37,537
+372
| +1% | +$42.7K |
|
98
LKQ Corp
LKQ
$8.31B
| $4.3M | 0.33% |
155,088
-8,766
| -5% | -$243K |
|
|
RDFN
99
DELISTED
Redfin
RDFN
| $4.22M | 0.33% |
+84,563
| New | +$4.22M |
|
100
Edwards Lifesciences
EW
$47.5B
| $4.13M | 0.32% |
51,740
+803
| +2% | +$64.1K |
|